Therapeutic Management of Postpartum Anoestrus in Dairy Cattle

Successful treatment of postpartum anoestrus begins with an accurate diagnosis. Since postpartum anoestrus is a clinical manifestation of different reproductive conditions rather than a single disease entity, treatment should always be guided by the underlying ovarian or uterine pathology. Selecting an appropriate therapeutic approach based on clinical findings helps improve reproductive efficiency while avoiding unnecessary interventions. 

In practice, management may involve hormonal therapy, treatment of concurrent uterine disease, induction of oestrus and ovulation, or supportive reproductive management, depending on the reproductive status of the individual animal. 

Managing Sub-Oestrous Animals¹ 

Sub-oestrous cows are characterized by the presence of a palpable corpus luteum despite the absence of observed oestrus. In these animals, prostaglandin therapy is commonly used to induce luteolysis and facilitate the onset of oestrus. 

Following treatment, fertile oestrus may occur within 2 to 6 days, depending on the stage of the oestrous cycle at the time of administration. Prostaglandin treatment has been reported to be effective in approximately 80% of cases, making it a practical option for appropriately selected animals. 

Treating Pyometra 

Pyometra commonly presents with accumulation of purulent material within the uterus and is frequently associated with a persistent corpus luteum. In these cases, prostaglandin administration serves multiple therapeutic purposes. 

Regression of the corpus luteum allows ovarian cyclicity to resume while also promoting evacuation of abnormal uterine contents and enhancing uterine defence mechanisms. 

Because relapse may occur, careful follow-up is important. Administration of a second prostaglandin dose 12 to 14 days after the initial treatment may be required. Breeding should only be considered after adequate healing of endometrial lesions, which may require one to three months^1,2. 

Managing Cystic Ovarian Disease¹ 

Cystic ovarian disease (COD) may involve either follicular or luteal cysts, both of which interfere with normal ovarian cyclicity. 

Although spontaneous recovery is possible, hormonal treatment may be indicated to support restoration of ovarian function. Biological preparations with LH-like activity, such as human chorionic gonadotropin (hCG), or exogenous GnRH are commonly used to induce luteinization of ovarian cysts. 

Approximately 80% of treated cows may exhibit fertile oestrus within 16 to 30 days following therapy. While pregnancy rates may remain slightly lower than those of unaffected cows, hormonal treatment supports the restoration of reproductive activity and maintenance of an optimal calving interval. 

For luteal cysts, prostaglandin therapy may be particularly effective when administered after GnRH treatment. Administering prostaglandin 9 to 14 days following GnRH helps shorten the interval between treatment and the first fertile oestrus compared with GnRH treatment alone. 

Therapeutic Options for Non-Responding Cows¹ 

Not all cows respond satisfactorily to GnRH therapy. In these animals, progesterone treatment may provide an alternative approach. 

Progesterone suppresses LH release temporarily, allowing LH to accumulate within the pituitary gland. Following withdrawal of progesterone, an enhanced LH surge may occur, promoting the resumption of oestrous cycles and improving reproductive performance. 

Inducing Oestrus and Ovulation¹ 

In cyclic cows affected by postpartum anoestrus, hormonal protocols may be used to stimulate follicular development and encourage ovulation. 

Progestogen-based therapies include progesterone-releasing intravaginal devices such as PRIDs or CIDRs, as well as ear implants containing norgestimate. Administration for 7 to 14 days sensitizes the hypothalamo-pituitary-gonadal axis, facilitating the onset of oestrus and ovulation. 

Pregnant mare serum gonadotropin (PMSG) may be administered at the time of progestogen removal to stimulate follicular growth and maturation, increasing the likelihood of successful oestrus and ovulation. 

Practical Clinical Insights 

Therapeutic success in postpartum anoestrus depends on matching treatment to the underlying reproductive condition rather than applying a uniform hormonal protocol to every case. Careful reproductive examination helps differentiate sub-oestrus, pyometra, cystic ovarian disease, and non-responding animals, allowing more appropriate treatment selection. Follow-up examinations remain equally important to assess treatment response, determine readiness for breeding, and identify animals requiring additional intervention.

A diagnosis-based therapeutic approach supports improved reproductive efficiency while helping veterinarians optimize fertility management in postpartum dairy herds. 

References 

1. Prasad UVSN, Prasad BC, Srinivas M, Radhika S, Naidu GV, Basha AK. Postpartum anoestrus in dairy cattle and its management: Review. Int J Vet Sci Anim Husb. 2025;10(2):184-190. https://www.veterinarypaper.com/pdf/2025/vol10issue2/PartC/10-2-36-968.pdf 

2. Lucy MC. Reproductive loss in high-producing dairy cattle: where will it end?. Journal of dairy science. 2001 Jun 1;84(6):1277-93. https://www.sciencedirect.com/science/article/pii/S0022030201701580/pdf?md5=6320217d334904222e88f2511359b5a1&pid=1-s2.0-S0022030201701580-main.pdf